- Statement of Changes in Beneficial Ownership (4)
18 Novembro 2008 - 10:32PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
LUCIER GREGORY T
|
2. Issuer Name
and
Ticker or Trading Symbol
INVITROGEN CORP
[
IVGN
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
CEO
|
(Last)
(First)
(Middle)
5791 VAN ALLEN WAY
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/14/2008
|
(Street)
CARLSBAD, CA 92008
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
(4)
|
11/14/2008
|
11/14/2008
|
P
|
V
|
37800
|
A
|
$26.42
|
185400
|
I
|
by trust
(1)
|
Common Stock
|
11/14/2008
|
11/14/2008
|
M
|
V
|
12000
|
A
|
$0.00
|
197400
|
I
|
by trust
|
Common Stock
(3)
|
11/14/2008
|
11/14/2008
|
F
|
V
|
5490
|
D
|
$25.05
|
191910
|
I
|
by trust
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Restricted Stock Unit
(2)
|
$0.00
|
11/14/2008
|
11/14/2008
|
M
|
V
|
|
12000
|
11/14/2008
|
11/14/2015
|
Common Stock
|
12000
|
$0.00
|
0
|
I
|
by trust
|
Restricted Stock Unit
(5)
|
$0.00
|
3/14/2008
|
3/14/2008
|
A
|
V
|
22532
|
|
3/14/2009
|
3/14/2018
|
Common Stock
|
22532
|
$0.00
|
22532
|
I
|
by trust
|
Explanation of Responses:
|
(
1)
|
Shares held in the Greg T. and Marilena Lucier Revocable Living Trust.
|
(
2)
|
Shares exercised and sold from grant # RS1016.
|
(
3)
|
This sale conducted to cover the sales price and tax liability resulting from the vesting of a restricted stock award.
|
(
4)
|
Open market purchase.
|
(
5)
|
Grant #RS2215, values are post-split.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
LUCIER GREGORY T
5791 VAN ALLEN WAY
CARLSBAD, CA 92008
|
|
|
CEO
|
|
Signatures
|
/s/ Joseph W. Secondine, Jr.
|
|
11/18/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Invitrogen (NASDAQ:IVGN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Invitrogen (NASDAQ:IVGN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Invitrogen (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de